The estimated Net Worth of Christopher Paige is at least 1.41 百万$ dollars as of 11 February 2020. Christopher Paige owns over 15,000 units of AvroBio Inc stock worth over 353,517$ and over the last 6 years he sold AVRO stock worth over 907,200$. In addition, he makes 145,303$ as Independent Director at AvroBio Inc.
Sign up
Christopher Paige AVRO stock SEC Form 4 insiders trading
Christopher has made over 3 trades of the AvroBio Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 15,000 units of AVRO stock worth 420,000$ on 11 February 2020.
The largest trade he's ever made was selling 15,000 units of AvroBio Inc stock on 11 February 2020 worth over 420,000$. On average, Christopher trades about 4,375 units every 39 days since 2019. As of 11 February 2020 he still owns at least 252,512 units of AvroBio Inc stock.
You can see the complete history of Christopher Paige stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Christopher Paige biography
Dr. Christopher Paige, Ph.D., serves as Independent Director of the Company. Dr. Paige is a senior scientist at University Health Network and a professor in the departments of medical biophysics and immunology at the University of Toronto, and has served in such roles since 1987. From 1997 to October 2016, he served as the vice president, research of the University Health Network. In 1990, Dr. Paige became the founding director of the Arthritis and Autoimmunity Research Centre as well as director of research at The Wellesley Hospital. He became a member of the Basel Institute for Immunology in Switzerland in 1980 where he worked until joining the Ontario Cancer Institute as a senior scientist in 1987. Dr. Paige also has experience serving on the board of directors of privately held companies. Dr. Paige earned a B.S. in biology at the University of Notre Dame in 1974 and a Ph.D. in immunology at the Sloan-Kettering Division of Cornell University Graduate School of Medical Sciences in 1979.
What is the salary of Christopher Paige?
As the Independent Director of AvroBio Inc, the total compensation of Christopher Paige at AvroBio Inc is 145,303$. There are 10 executives at AvroBio Inc getting paid more, with Birgitte Volck having the highest compensation of 4,384,270$.
How old is Christopher Paige?
Christopher Paige is 67, he's been the Independent Director of AvroBio Inc since 2016. There are no older and 20 younger executives at AvroBio Inc.
What's Christopher Paige's mailing address?
Christopher's mailing address filed with the SEC is C/O AVROBIO, INC., 100 TECHNOLOGY SQUARE, 6TH FLOOR, CAMBRIDGE, MA, 02139.
Insiders trading at AvroBio Inc
Over the last 6 years, insiders at AvroBio Inc have traded over 3,066,308$ worth of AvroBio Inc stock and bought 2,395,057 units worth 31,037,133$ . The most active insiders traders include Braden Michael Leonard、Bruce Booth、Venture Fund X, L.P.Atlas V.... On average, AvroBio Inc executives and independent directors trade stock every 102 days with the average trade being worth of 206,675$. The most recent stock trade was executed by Braden Michael Leonard on 13 May 2024, trading 766,635 units of AVRO stock currently worth 973,626$.
What does AvroBio Inc do?
clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.
What does AvroBio Inc's logo look like?
Complete history of Christopher Paige stock trades at AvroBio Inc
AvroBio Inc executives and stock owners
AvroBio Inc executives and other stock owners filed with the SEC include:
-
Birgitte Volck,
President - Research & Development -
Erik Ostrowski,
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, Treasurer -
Geoff MacKay,
President, Chief Executive Officer, Director -
Steven Avruch,
Secretary, Chief Legal Officer -
Geoff MacKay BSc,
Co- Founder, Pres, CEO & Director -
Geoff MacKay,
Co- Founder, Pres, CEO & Director -
Erik Ostrowski M.B.A.,
CFO & Treasurer -
Steven N. Avruch J.D.,
Chief Legal Officer & Sec. -
Philip Vickers,
Independent Director -
Bruce Booth,
Independent Chairman of the Board -
Christopher Paige,
Independent Director -
Phillip Donenberg,
Independent Director -
Annalisa Jenkins,
Independent Director -
Ian Clark,
Independent Director -
Gail Farfel,
Director -
Kim Raineri,
Chief Manufacturing and Technology Officer -
Chris Brinzey,
IR Contact Officer -
Deanna Petersen,
Chief Business Officer -
Dr. Essra Ridha FFPM, M.D.,
Chief Medical Officer -
Andreas Kouri,
Sr. VP of Global Supply Chain & External Manufacturing -
Azadeh Golipour Ph.D.,
Chief Technology Officer -
Deanna M. Petersen MBA,
Chief Bus. Officer -
Dr. Christopher Mason FMEDSCI, FRCS, M.D., Ph.D.,
Chief Scientific Officer -
Dr. Christopher Mason FMEDSCI, M.D., Ph.D., FRCS,
Chief Scientific Officer -
Deanna M. Petersen M.B.A., MBA,
Chief Bus. Officer -
Georgette Verdin,
Chief HR Officer -
Monique Da Silva,
Sr. VP of Corp. Communications -
Dr. Christopher Mason,
Chief Scientific Officer -
Kim Raineri M.B.A.,
Chief Manufacturing & Technology Officer -
Matthew Arnold,
Head of Operations -
Jeffrey Medin Ph.D.,
Scientific Founder -
Venture Fund X, L.P.Atlas V...,
-
Lifesciences Iii, L.P.Claru...,
-
Scott Requadt,
Director -
Vi, Llcsv Life Sciences Fun...,
-
Katina Dorton,
Chief Financial Officer -
Nerissa Kreher,
Chief Medical Officer -
Venture Associates X, L.P. ...,
10% owner -
Lifesciences Iii, L.P.Claru...,
-
Diana Escolar,
Chief Medical Officer -
Christopher Mason,
Chief Scientific Officer -
Essra Ridha,
Chief Medical Officer -
Azadeh Golipour,
Chief Technology Officer -
Braden Michael Leonard,